BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28925486)

  • 1. Long non-coding RNA FOXD2-AS1 functions as a tumor promoter in colorectal cancer by regulating EMT and Notch signaling pathway.
    Yang X; Duan B; Zhou X
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3586-3591. PubMed ID: 28925486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.
    Lei T; Zhu X; Zhu K; Jia F; Li S
    Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
    Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
    Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
    Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
    Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H; Cao W; Xue J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA FOXD2-AS1 contributes to colorectal cancer proliferation through its interaction with microRNA-185-5p.
    Zhu Y; Qiao L; Zhou Y; Ma N; Wang C; Zhou J
    Cancer Sci; 2018 Jul; 109(7):2235-2242. PubMed ID: 29737580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
    Han X; Wang L; Ning Y; Li S; Wang Z
    Biol Res; 2016 Aug; 49(1):36. PubMed ID: 27578191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
    [No Abstract]   [Full Text] [Related]  

  • 13. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
    Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
    J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
    Hu Q; Tai S; Wang J
    Pathol Res Pract; 2019 May; 215(5):843-848. PubMed ID: 30723052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
    Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2.
    Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma.
    Ren W; Zhu Z; Wu L
    J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
    Liu XB; Han C; Sun CZ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):110-117. PubMed ID: 29364477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.